5-nitro-2-(3-phenylpropylamino)benzoic acid and n-propionylprocainamide

5-nitro-2-(3-phenylpropylamino)benzoic acid has been researched along with n-propionylprocainamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Book, M; Hahn, M; Luedi, MM; Rieder, HU; Stamer, UM; Stüber, F1
Chen, W; Fang, Y; Guo, N; Guo, Q; Lv, J; Wang, Z; Zeng, S; Zhao, Z1

Other Studies

2 other study(ies) available for 5-nitro-2-(3-phenylpropylamino)benzoic acid and n-propionylprocainamide

ArticleYear
ASA Status,
    Cells, 2022, 02-22, Volume: 11, Issue:5

    Topics: Atrial Natriuretic Factor; Coronary Artery Disease; Haplotypes; Humans; Natriuretic Peptide, Brain; Natriuretic Peptides; Nitrobenzoates; Peptide Fragments; Procainamide

2022
Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
    Current drug targets, 2023, Volume: 24, Issue:4

    Topics: Animals; Cardiomegaly; Histone Deacetylase Inhibitors; Histones; Myocytes, Cardiac; Natriuretic Peptides; Phenylephrine; Rats

2023